Arrowhead Pharmaceuticals, Inc.
ARWR
$65.00
-$0.08-0.12%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 35.43% | 106.73% | 110.27% | 158.15% | 71.19% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 14.64% | 157.33% | 115.65% | -10.94% | 8.22% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 81.94% | 140.60% | 41.83% | -44.05% | -29.00% |
| Total Current Assets | 36.69% | 110.40% | 109.59% | 139.82% | 66.99% |
|
|
|||||
| Total Current Assets | 36.69% | 110.40% | 109.59% | 139.82% | 66.99% |
| Net Property, Plant & Equipment | -1.13% | 1.14% | 6.28% | 14.17% | 28.53% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -19.87% | -18.93% | -18.07% | -17.28% | -16.57% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -69.01% | -69.66% | 524.76% | 1,228.88% | 37.53% |
| Total Assets | 21.54% | 56.22% | 64.74% | 61.86% | 48.89% |
|
|
|||||
| Total Accounts Payable | 55.20% | 24.48% | 17.12% | 224.15% | -68.25% |
| Total Accrued Expenses | 19.11% | 47.52% | 117.56% | 54.46% | 84.97% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 645.65% | 676.64% | 1,258.22% | 139.26% | -39.96% |
| Total Finance Division Other Current Liabilities | 639.24% | 319.06% | 462.31% | -74.35% | -69.78% |
| Total Other Current Liabilities | 639.24% | 319.06% | 462.31% | -74.35% | -69.78% |
| Total Current Liabilities | 89.48% | 101.14% | 238.38% | 47.13% | -2.17% |
|
|
|||||
| Total Current Liabilities | 89.48% | 101.14% | 238.38% | 47.13% | -2.17% |
| Long-Term Debt | -20.73% | 66.83% | 99.76% | 175.70% | 173.75% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -6.23% | -5.67% | -5.37% | -5.09% | 6.14% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -7.05% | 58.01% | 93.43% | 111.59% | 98.32% |
|
|
|||||
| Common Stock & APIC | 18.48% | 18.69% | 19.11% | 39.87% | 38.88% |
| Retained Earnings | -0.10% | -10.20% | -11.21% | -55.20% | -58.43% |
| Treasury Stock & Other | -1,084.21% | 642.76% | 500.91% | 429.64% | 247.42% |
| Total Common Equity | 151.32% | 58.01% | 41.24% | -67.22% | -31.66% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 151.32% | 58.01% | 41.24% | -67.22% | -31.66% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 564.96% | -129.75% | -92.21% | -73.80% | -64.48% |
| Total Equity | 163.48% | 53.35% | 38.11% | -67.72% | -33.47% |
|
|
|||||